Latest filing published 25 Jan 2024 for Madrigal Pharmaceuticals, INC..
Insider track record
Brian Joseph Lynch: trading record in brief
This profile gathers the share dealings of Brian Joseph Lynch in Madrigal Pharmaceuticals, Inc. We count 42 filings; the first trade dates from 23 December 2022 and the latest from 23 January 2024.
On the market, this insider has only sold: 32 sales, €7.1M in total. Outside the open market, there are 3 share grants and 7 option exercises.
The newest entry dates from 25 January 2024: a share grant, in Madrigal Pharmaceuticals, Inc. Typically, a trade is published a median of 3 days after it takes place. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Brian Joseph Lynch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,639 shares0Common StockSEC:0000950170-24-007348:0
- 949 shares@ US$243.929.4% of flowCommon StockSEC:0000950170-24-005304:0
- 800 shares@ US$73.752.4% of flowCommon StockSEC:0000950170-23-068575:0
- 4,000 shares@ US$73.7511.9% of flowCommon StockSEC:0000950170-23-067360:0
- 15,001 shares0Common StockSEC:0000899243-23-002097:0
- 13,000 shares@ US$91.7949.5% of flowCommon StockSEC:0000899243-23-001137:0
- 7,000 shares@ US$91.7926.8% of flowCommon StockSEC:0000899243-22-039464:0
7 of 7 declarations
